67MO Neoadjuvant and adjuvant toripalimab in high-risk locoregionally advanced nasopharyngeal carcinoma: A randomised, double-blind, placebo-controlled, phase II trial

H. Mai,S-L. Liu, J.H. Yang, D.X. Wen,S-S. Guo,L. Liu, M-J. Luo,Y-J. Liang,X-S. Sun,X-Y. Li, L. Donghua, J-B. Li, P. Wang, L. Guo, H-Y. Mo, R. Sun, C. Zhao,R-H. Xu,Q.Y. Chen, L.Q. Tang

Immuno-Oncology and Technology(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要